中国平安(601318):进可攻、退可守的欠配高股息标的
Shenwan Hongyuan Securities·2025-12-30 14:03

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The insurance sector is expected to undergo a value reassessment, with the company demonstrating significant advantages in managing liability costs and outperforming peers in interest spread performance [6][24] - The company has a strong focus on shareholder returns, with a consistent increase in dividends over the past 13 years, and a projected dividend yield of 4.0% for A shares and 4.5% for H shares in 2025 [8][12] - The company is expected to benefit from a stable long-term interest rate environment and ongoing asset allocation improvements, which will enhance investment returns [31][33] Summary by Sections 1. Insurance Sector Revaluation - Concerns over interest spread losses have become a core factor affecting the valuation of life insurance companies, with the average P/EV of A-share listed insurance companies dropping below 1.0x since 2021 [23] - The company has the lowest new liability cost among A-share insurers at 2.42% for 2024, and a stock liability cost of 2.50%, indicating strong management capabilities [25] 2. Fundamental Improvement and NBV Growth - The company's net profit for the first three quarters of 2025 increased by 11.5% year-on-year, driven by strong investment performance and improved operational metrics [7][37] - The company’s NBV (New Business Value) growth is robust, with a year-on-year increase of 28.8% in 2024 and 46.2% in the first three quarters of 2025 [53] - The company’s diversified channel strategy is yielding results, with the bancassurance channel expected to continue contributing significantly to NBV growth [60][71] 3. High Dividend Characteristics - The company is currently underweighted by public funds compared to the CSI 300 index, which may lead to increased capital inflows as market conditions stabilize [8][12] - The company’s dividend mechanism based on OPAT (Operating Profit After Tax) is expected to support a recovery in double-digit growth for OPAT in 2026 [8][12] 4. Financial Forecast and Valuation - The company’s projected net profit for 2025-2027 is expected to reach 1,468 billion, 1,612 billion, and 1,880 billion respectively, with year-on-year growth rates of 15.9%, 9.9%, and 16.6% [12] - The estimated company value for 2026 is projected at 1.70 trillion RMB, with a target price of 93.8 RMB per share, corresponding to a P/EV of 0.99x [12]